Literature DB >> 23132717

Study of efficiency of the modular nanotransporter for targeted delivery of photosensitizers to melanoma cell nuclei in vivo.

T A Slastnikova1, A A Rosenkranz, T N Lupanova, P V Gulak, N V Gnuchev, A S Sobolev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23132717      PMCID： PMC3646556          DOI： 10.1134/S1607672912050146

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  10 in total

1.  Recombinant modular transporters for cell-specific nuclear delivery of locally acting drugs enhance photosensitizer activity.

Authors:  Andrey A Rosenkranz; Vladimir G Lunin; Pavel V Gulak; Olga V Sergienko; Maria A Shumiantseva; Olga L Voronina; Dinara G Gilyazova; Anna P John; Anna A Kofner; Andrey F Mironov; David A Jans; Alexander S Sobolev
Journal:  FASEB J       Date:  2003-04-08       Impact factor: 5.191

Review 2.  [Approaches to the targeted intracellular delivery of photosensitizers in order to enhance their efficacy and cell specificity].

Authors:  A S Sobolev; A A Rozenkrants; D G Giliazova
Journal:  Biofizika       Date:  2004 Mar-Apr

3.  Fluence rate effects on photodynamic therapy of B16 pigmented melanoma.

Authors:  N Michailov; M Peeva; I Angelov; D Wohrle; S Muller; G Jori; F Ricchelli; M Shopova
Journal:  J Photochem Photobiol B       Date:  1997-01       Impact factor: 6.252

4.  Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin.

Authors:  K W Woodburn; Q Fan; D Kessel; Y Luo; S W Young
Journal:  J Invest Dermatol       Date:  1998-05       Impact factor: 8.551

5.  Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins.

Authors:  Ganesan Vaidyanathan; Michael R Zalutsky
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 6.  Combating melanoma: the use of photodynamic therapy as a novel, adjuvant therapeutic tool.

Authors:  L M Davids; B Kleemann
Journal:  Cancer Treat Rev       Date:  2010-12-17       Impact factor: 12.111

7.  [Targeted intracellular site-specific drug delivery: photosensitizer targeting to melanoma cell nuclei].

Authors:  A A Rozenkrants; V G Lunin; O V Sergienko; D G Giliazova; O L Voronina; D E Ians; A A Kofner; M A Shumiantseva; A F Mironov; A S Sobolev
Journal:  Genetika       Date:  2003-02

8.  A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.

Authors:  G Jori; M Soncin; E Friso; M G H Vicente; E Hao; G Miotto; P Colautti; D Moro; J Esposito; G Rosi; E Nava; G Sotti; C Fabris
Journal:  Appl Radiat Isot       Date:  2009-03-27       Impact factor: 1.513

9.  Tumour-localizing and -photosensitising properties of meso-tetra(4-nido-carboranylphenyl)porphyrin (H2TCP).

Authors:  Clara Fabris; M Graça H Vicente; Erhong Hao; Elisabetta Friso; Lara Borsetto; Giulio Jori; Giovanni Miotto; Paolo Colautti; Davide Moro; Juan Esposito; Alice Ferretti; Carlo Riccardo Rossi; Donato Nitti; Guido Sotti; Marina Soncin
Journal:  J Photochem Photobiol B       Date:  2007-10-01       Impact factor: 6.252

10.  Silkworm-pheophorbide alpha mediated photodynamic therapy against B16F10 pigmented melanoma.

Authors:  Dae-Seog Lim; Si-Hwan Ko; Won-Young Lee
Journal:  J Photochem Photobiol B       Date:  2004-03-19       Impact factor: 6.252
  10 in total
  9 in total

Review 1.  Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Michael R Zalutsky; Alexander S Sobolev
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 2.  Nanomedicine in the application of uveal melanoma.

Authors:  Shuo You; Jing Luo; Hans E Grossniklaus; Ma-Ling Gou; Ke Meng; Qing Zhang
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

3.  Study of Biodistribution of the Modular Nanotransporters after Systemic Administration in Murine Cloudman S91 Melanoma Model.

Authors:  Y V Khramtsov; A V Ulasov; A A Rosenkranz; G P Georgiev; A S Sobolev
Journal:  Dokl Biochem Biophys       Date:  2018-03-14       Impact factor: 0.788

Review 4.  Malignant melanoma and melanocortin 1 receptor.

Authors:  A A Rosenkranz; T A Slastnikova; M O Durymanov; A S Sobolev
Journal:  Biochemistry (Mosc)       Date:  2013-11       Impact factor: 2.487

5.  Preparation, cytotoxicity, and in vivo antitumor efficacy of 111In-labeled modular nanotransporters.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Natalia B Morozova; Maria S Vorontsova; Vasiliy M Petriev; Tatiana N Lupanova; Alexey V Ulasov; Michael R Zalutsky; Raisa I Yakubovskaya; Alexander S Sobolev
Journal:  Int J Nanomedicine       Date:  2017-01-10

Review 6.  Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters.

Authors:  Alexander S Sobolev
Journal:  Front Pharmacol       Date:  2018-08-27       Impact factor: 5.810

Review 7.  Targeted Intracellular Delivery of Antibodies: The State of the Art.

Authors:  Tatiana A Slastnikova; A V Ulasov; A A Rosenkranz; A S Sobolev
Journal:  Front Pharmacol       Date:  2018-10-24       Impact factor: 5.810

8.  The Delivery of Biologically Active Agents into the Nuclei of Target Cells for the Purposes of Translational Medicine.

Authors:  A S Sobolev
Journal:  Acta Naturae       Date:  2020 Oct-Dec       Impact factor: 1.845

9.  Toxicity and Immunogenicity in Murine Melanoma following Exposure to Physical Plasma-Derived Oxidants.

Authors:  Sander Bekeschus; Katrin Rödder; Bob Fregin; Oliver Otto; Maxi Lippert; Klaus-Dieter Weltmann; Kristian Wende; Anke Schmidt; Rajesh Kumar Gandhirajan
Journal:  Oxid Med Cell Longev       Date:  2017-06-27       Impact factor: 6.543
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.